|
HNRNPUL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.796200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.268100E-02 |
| Normal-vs-Stage2 |
2.976400E-01 |
| Normal-vs-Stage3 |
3.672300E-02 |
| Normal-vs-Stage4 |
3.534200E-01 |
| Stage1-vs-Stage2 |
7.506200E-01 |
| Stage1-vs-Stage3 |
6.690400E-01 |
| Stage1-vs-Stage4 |
4.178000E-01 |
| Stage2-vs-Stage3 |
5.653200E-01 |
| Stage2-vs-Stage4 |
7.812200E-01 |
| Stage3-vs-Stage4 |
3.307400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.383800E-02 |
| Normal-vs-AfricanAmerican |
6.131400E-01 |
| Normal-vs-Asian |
9.450200E-01 |
| Caucasian-vs-AfricanAmerican |
8.310000E-02 |
| Caucasian-vs-Asian |
1.023960E-01 |
| AfricanAmerican-vs-Asian |
6.285400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.166000E-01 |
| Normal-vs-Female |
2.596100E-02 |
| Male-vs-Female |
3.660200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.498300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.209760E-01 |
| Normal-vs-Age(61-80Yrs) |
1.479950E-02 |
| Normal-vs-Age(81-100Yrs) |
7.945800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.181400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.732600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.532200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.358200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.484000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.298000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.066450E-01 |
| Classical-VS-Follicular |
3.198300E-04 |
| Classical-VS-Other |
1.313570E-01 |
| Classical-VS-Normal |
6.191000E-01 |
| Tall-VS-Follicular |
2.528600E-01 |
| Tall-VS-Other |
5.109400E-01 |
| Tall-VS-Normal |
5.801500E-02 |
| Follicular-VS-Other |
9.695800E-01 |
| Follicular-VS-Normal |
8.786700E-04 |
| Other-VS-Normal |
8.064100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.617700E-02 |
| Normal-vs-N1 |
3.624500E-02 |
| N0-vs-N1 |
7.608600E-01 |
|
|
